Compounded medications are not FDA-approved as a class (unlike branded versions), but are permitted under 503A licensing
Despite all the changes, it seems likely that compounding pharmacies will continue to offer GLP-1 drugs, at least for the foreseeable future, says Brunner: Some patients will be able to maintain these therapies at a price point they can afford in a customized formulation. The Takeaway The FDA ordered compounding pharmacies to stop producing and selling copies of GLP-1 injectable drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, as official shortages have ended
is a co-inventor on intellectual property owned by Indiana University and licensed to Novo Nordisk
Myers' Cocktail can help improve your mood and energy
Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, et al